Takeda Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 12,000 | 0.000757% |
Public Companies | 275,000 | 0.0173% |
Individual Insiders | 968,685 | 0.0611% |
Company Controlled Foundation | 17,912,000 | 1.13% |
Institutions | 749,104,764 | 47.3% |
General Public | 816,908,145 | 51.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
117,311,056 | US$3.3b | 0.19% | 0.05% | |||
72,725,600 | US$2.0b | -0.47% | 0.65% | |||
60,710,631 | US$1.7b | 0% | 0.02% | |||
50,891,334 | US$1.4b | 0% | 0.92% | |||
42,560,977 | US$1.2b | -1.18% | 0.05% | |||
36,509,500 | US$1.0b | 0% | 0.35% | |||
33,150,000 | US$926.2m | 50.5% | 2.57% | |||
31,941,500 | US$892.4m | -1.45% | 0.59% | |||
29,501,697 | US$824.2m | 26.1% | 0.34% | |||
24,752,000 | US$691.5m | 0% | 0.73% | |||
23,923,467 | US$668.4m | 0% | 0.05% | |||
18,683,200 | US$522.0m | 0.32% | 0.27% | |||
17,912,000 | US$500.4m | 0% | no data | |||
14,434,643 | US$403.3m | 0% | 0.03% | |||
9,166,907 | US$256.1m | 0.9% | 0.04% | |||
8,074,200 | US$225.6m | 0% | 0.44% | |||
7,374,792 | US$206.0m | 1.58% | 0.02% | |||
6,846,750 | US$191.3m | -0.03% | 0.05% | |||
6,625,900 | US$185.1m | 0% | 0.51% | |||
5,822,502 | US$162.7m | 0.71% | 0.02% | |||
5,421,524 | US$151.5m | 0.58% | 0.01% | |||
5,336,696 | US$149.1m | 0.01% | 0.58% | |||
5,334,600 | US$149.0m | -0.93% | 0.17% | |||
4,615,640 | US$129.0m | 0.03% | 0.03% | |||
4,480,198 | US$125.2m | 104% | 0.01% |